Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., commonly referred to as Xiuzheng Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jilin City, China. Established in 1998, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, catering to both domestic and international markets. With a diverse portfolio that includes herbal medicines, chemical drugs, and health supplements, Xiuzheng Pharmaceutical stands out for its commitment to quality and innovation. The company has achieved notable milestones, including various certifications and recognitions that underscore its market position. As a leader in the pharmaceutical sector, Xiuzheng continues to expand its operational footprint, contributing to advancements in healthcare and wellness solutions.
DitchCarbon Score
How does Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s reported carbon emissions
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Jilin Xiuzheng Pharmaceutical Group aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for emissions reductions. In summary, without available data or commitments, Jilin Xiuzheng Pharmaceutical Group's current stance on carbon emissions and climate action remains undefined.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
